These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 19960185)
1. The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review. Peppone LJ; Hebl S; Purnell JQ; Reid ME; Rosier RN; Mustian KM; Palesh OG; Huston AJ; Ling MN; Morrow GR Osteoporos Int; 2010 Jul; 21(7):1133-49. PubMed ID: 19960185 [TBL] [Abstract][Full Text] [Related]
2. Management of osteoporosis with calcitriol in elderly Chinese patients: a systematic review. Liao RX; Yu M; Jiang Y; Xia W Clin Interv Aging; 2014; 9():515-26. PubMed ID: 24729692 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Richy F; Ethgen O; Bruyere O; Reginster JY Osteoporos Int; 2004 Apr; 15(4):301-10. PubMed ID: 14740153 [TBL] [Abstract][Full Text] [Related]
4. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis. Jones G; Hogan DB; Yendt E; Hanley DA CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis. Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726 [TBL] [Abstract][Full Text] [Related]
6. Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT). Sugimoto T; Matsumoto T; Hosoi T; Miki T; Gorai I; Yoshikawa H; Tanaka Y; Tanaka S; Fukunaga M; Sone T; Nakano T; Ito M; Matsui S; Yoneda T; Takami H; Watanabe K; Osakabe T; Okubo N; Shiraki M; Nakamura T Osteoporos Int; 2015 Feb; 26(2):765-74. PubMed ID: 25403903 [TBL] [Abstract][Full Text] [Related]
7. The role of vitamin D in the pathogenesis and treatment of osteoporosis. Gallagher JC J Rheumatol Suppl; 1996 Aug; 45():15-8. PubMed ID: 8856646 [TBL] [Abstract][Full Text] [Related]
8. Management of postmenopausal osteoporosis and the prevention of fractures. Gambacciani M; Levancini M Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322 [TBL] [Abstract][Full Text] [Related]
10. One year in review 2018: progress in osteoporosis treatment. Figliomeni A; Signorini V; Mazzantini M Clin Exp Rheumatol; 2018; 36(6):948-958. PubMed ID: 30526765 [TBL] [Abstract][Full Text] [Related]
11. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss. Reginster JY; Lecart MP; Richy F J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847 [TBL] [Abstract][Full Text] [Related]
12. Potential of alfacalcidol for reducing increased risk of falls and fractures. Ringe JD; Schacht E Rheumatol Int; 2009 Aug; 29(10):1177-85. PubMed ID: 19159932 [TBL] [Abstract][Full Text] [Related]
13. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures. Schacht E; Richy F; Reginster JY J Musculoskelet Neuronal Interact; 2005; 5(3):273-84. PubMed ID: 16172518 [TBL] [Abstract][Full Text] [Related]
14. The Pharmacologic Management of Osteoporosis in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. Danford CJ; Ezaz G; Trivedi HD; Tapper EB; Bonder A J Clin Densitom; 2020; 23(2):223-236. PubMed ID: 31146965 [TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease and osteoporosis. van den Bos F; Speelman AD; Samson M; Munneke M; Bloem BR; Verhaar HJ Age Ageing; 2013 Mar; 42(2):156-62. PubMed ID: 23132148 [TBL] [Abstract][Full Text] [Related]
17. Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. Meunier PJ; Roux C; Ortolani S; Diaz-Curiel M; Compston J; Marquis P; Cormier C; Isaia G; Badurski J; Wark JD; Collette J; Reginster JY Osteoporos Int; 2009 Oct; 20(10):1663-73. PubMed ID: 19153678 [TBL] [Abstract][Full Text] [Related]
18. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733 [TBL] [Abstract][Full Text] [Related]
19. Novel advances in the treatment of osteoporosis. Chan CK; Mason A; Cooper C; Dennison E Br Med Bull; 2016 Sep; 119(1):129-42. PubMed ID: 27558130 [TBL] [Abstract][Full Text] [Related]
20. Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials. Lou S; Lv H; Yin P; Li Z; Tang P; Wang Y Osteoporos Int; 2019 Jan; 30(1):59-70. PubMed ID: 30539271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]